Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for bcl 2
Most Correlated Studies
- Surviving Sepsis: Bcl-2 Overexpression Modulates Splenocyte Transcriptional Responses
- Tumors derived from atg5-/- Bcl-2 iBMK cells expressing p62
- Bcl-2 inhibiton in peripheral blood of chronic lymphocytic leukemia patients
- Keratinocytes HaCat cell line with BCL-3 overexpression
- Embryonic stem cells overexpressing BCL-XL with induced AKAP-13 shRNA knockdown
Most Relevant Literature
- Enhancing dendritic cells by inhibiting BCL2.
- Expanding roles of BCL-2 proteins in apoptosis execution and beyond.
- Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
- bcl-2 and p53 as novel biomarkers for predicting malignant transformation in chronic osteomyelitis.
- Targeting RNA Splicing Overcomes Leukemia Resistance to BCL2 Inhibition.
Most Relevant Clinical Trials
- Use of Venetoclax as Single Agent in Patients With Relapsed/Refractory BCL-2 Positive Peripheral T C…
- Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer
- Italian Observational Study of Patients With Acute Myeloid Leukemia Treated With Small Molecule Inhi…
- Study of Bcl-2 Inhibitor BGB-11417 in Participants With Mature B-Cell Malignancies
- Phase 1 Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies
